Managing Directors
Gabi Baus, Graduate Economist
Managing Director
Gabi Baus is pharma-insight GmbH’s founder and managing director. In addition to being a qualified health professional, she holds a graduate degree in Economics, specialising in marketing and market research. Gabi Baus has extensive expertise and industry knowledge, based on more than 30 years of hands-on experience in a clinical setting, the pharmaceutical industry as well as in market research.
Anton Richter
Chief Executive Officer, M3 Global Research
Anton Richter is an industry veteran, with nearly 20 years of healthcare market research experience. He joined M3 in 2014, and during his tenure has held roles as sales director, managing director and now CEO of The M3GR Group, which includes M3 Global Research (UK and USA), QQFS (Sweden), m360 Research (India), Ekas (Australia), and pharma-insight (Germany). Over the last five years, he has led the organisation through a period of exponential growth supported by strategic acquisitions and continues to have ambitions to grow M3’s research operations further.
A former EphMRA board member, elected by his peers, he is an expert in global data collection, with a strong focus on customer experience, communication and quality. He is passionate about driving initiatives to raise standards in the industry and improve healthcare market research and has embedded these principles in the culture of M3, at every level of the organisation.
Akihiko Tomaru
Chief Executive Officer, M3 USA
As the founding member and CEO of M3 USA—an M3 Inc. subsidiary—since its inception, Aki has been the driving force behind M3 Inc.’s ventures into digital healthcare platforms across the US and throughout Europe.
Under Aki’s leadership, M3, Inc. has expanded its reach into the US, the UK, France, Germany, Spain, and Sweden. In these countries, M3, Inc. delivers digital solutions for clinical research, market research, physician recruitment, pharmaceutical promotion and clinical decision-making and EHR support.
Aki regularly collaborates with various partners such as pharmaceutical companies, publishers, hospitals, CROs, and other solutions providers to improve the efficiencies and quality of healthcare-related industries and to advance efforts towards progressive healthcare.
M3 Inc., is a publicly-traded company that is a global leader in healthcare solutions. Aki has served on M3, Inc.’s Board of Directors since 2012. Prior to joining M3, Aki was a management consultant at McKinsey & Company in Tokyo and California. He holds an MBA from Harvard Business School.
Heads of Department
M. A. Michelle Kühn
Senior Research Director
Michelle Kühn is part of pharma-insights core team since 2012.
In addition to her studies in sociology, Michelle Kühn possesses extensive qualitative and quantitative knowledge, which makes her a real „allrounder“ in medical market research.
Her particular interest comprises the integration of neuro-scientific tools.
M. A. Christopher Baus
Senior Research Director
Christopher Baus holds a graduate degree in linguistics and psychology and is active in market research for over 12 years now.
As an experienced moderator and analyst, Christopher Baus takes care of qualitative market research projects at pharma-insight GmbH since 2012.
Besides his extensive methodical and medical know-how, he is responsible for adverse event management and staff training.
Jacqueline Baus
Head of Field Department
Jacqueline Baus has been a member of the pharma-insight GmbH team since 2010. After her training as a specialist in market and social research, she initially gained experience in qualitative and quantitative research as a junior researcher.
In 2016, she moved to the Field Department, which she took over in 2019. In addition to the operational management of the Field Department, she is responsible for the further development of the Healthcare Panel and all aspects related to data protection.